🔴 We are now live with an engaging presentation by Prof. Georg F. Weber, MD, PhD, Professor at Friedrich-Alexander University Erlangen-Nürnberg (FAU), Germany, discussing the transformative role of liquid biopsy in pancreatic cancer management.
Presentation: Liquid Biopsy in Pancreatic Cancer – Advances in Diagnosis and Treatment Stratification
Pancreatic cancer remains one of the most challenging malignancies to diagnose and treat, making the development of reliable, minimally invasive biomarkers a critical priority. In this session, Prof. Weber is exploring how liquid biopsy technologies are advancing the early detection, molecular characterization, and personalized treatment of pancreatic cancer.
Drawing on his expertise in translational oncology and biomarker research, Prof. Weber highlights recent advances in the use of circulating DNA, RNA, and protein biomarkers to improve diagnostic accuracy, identify clinically relevant molecular alterations, and support more effective treatment stratification.
The presentation also examines how liquid biopsy enables real-time disease monitoring, assessment of treatment response, and earlier detection of disease progression, providing clinicians with valuable tools to guide precision medicine and improve patient outcomes.
This insightful session showcases the growing impact of liquid biopsy in addressing one of oncology’s greatest challenges and underscores its potential to transform pancreatic cancer care.
We extend our sincere thanks to Prof. Georg F. Weber for sharing his expertise and to our global audience for joining us in this scientific exchange.
This conference is organized by Impact Research Communications (IRC)
More info: https://liquidbio.ircconferences.net/ | Advances in Liquid Biopsy
